-
1
Study focused on diacerein's efficacy for knee OA.
-
2
Patients had MRI-confirmed effusion-synovitis.
-
3
Results showed no significant pain relief versus placebo.
-
4
Both groups had similar VAS and functional score reductions.
-
5
Diacerein group reported more gastrointestinal issues.
-
6
Study involved 262 adults with a mean age of 54.9 years.
-
7
Findings may not apply to all OA patients.
-
8
Limitations included imaging without contrast for pathology distinction.
Original Source(s)
Related Content
The Missing Step in Pediatric Lupus Care
Survey data show gaps between rheumatologists’ beliefs and clinical practice in screening and neuropsychological evaluation for childhood-onset systemic lupus erythematosus
by Henry Thomas
March 17, 2026
-
2 min
Dry Eye Across Autoimmune Diseases
The nationwide analysis found the highest rates of dry eye disease among patients with Sjögren’s syndrome.
March 13, 2026
-
3 min
PsA Treatment Options Expand
Phase 3 POETYK trial results support FDA approval of deucravacitinib for adults with active PsA.
March 9, 2026
-
3 min
